IL17A and rheumatoid arthritis: Takaki-Kuwahara and colleagues reported that CCR6+ILC3s increases in joints of arthritic mice and patients with RA, and CCR6+ILC3s may participate in the development of RA by producing IL-17 and IL-22 [10].